Your browser doesn't support javascript.
loading
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.
Horak, Peter; Heining, Christoph; Kreutzfeldt, Simon; Hutter, Barbara; Mock, Andreas; Hüllein, Jennifer; Fröhlich, Martina; Uhrig, Sebastian; Jahn, Arne; Rump, Andreas; Gieldon, Laura; Möhrmann, Lino; Hanf, Dorothea; Teleanu, Veronica; Heilig, Christoph E; Lipka, Daniel B; Allgäuer, Michael; Ruhnke, Leo; Laßmann, Andreas; Endris, Volker; Neumann, Olaf; Penzel, Roland; Beck, Katja; Richter, Daniela; Winter, Ulrike; Wolf, Stephan; Pfütze, Katrin; Geörg, Christina; Meißburger, Bettina; Buchhalter, Ivo; Augustin, Marinela; Aulitzky, Walter E; Hohenberger, Peter; Kroiss, Matthias; Schirmacher, Peter; Schlenk, Richard F; Keilholz, Ulrich; Klauschen, Frederick; Folprecht, Gunnar; Bauer, Sebastian; Siveke, Jens Thomas; Brandts, Christian H; Kindler, Thomas; Boerries, Melanie; Illert, Anna L; von Bubnoff, Nikolas; Jost, Philipp J; Spiekermann, Karsten; Bitzer, Michael; Schulze-Osthoff, Klaus.
Afiliação
  • Horak P; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Heining C; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Kreutzfeldt S; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.
  • Hutter B; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Mock A; DKTK, Dresden, Germany.
  • Hüllein J; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Fröhlich M; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Uhrig S; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.
  • Jahn A; Division of Applied Bioinformatics, DKFZ, Heidelberg.
  • Rump A; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Gieldon L; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Möhrmann L; Department of Medical Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.
  • Hanf D; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.
  • Teleanu V; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.
  • Heilig CE; Division of Applied Bioinformatics, DKFZ, Heidelberg.
  • Lipka DB; Computational Oncology Group, Molecular Diagnostics Program, NCT Heidelberg and DKFZ, Heidelberg, Germany.
  • Allgäuer M; Division of Applied Bioinformatics, DKFZ, Heidelberg.
  • Ruhnke L; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Laßmann A; DKTK, Dresden, Germany.
  • Endris V; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Neumann O; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Penzel R; DKTK, Dresden, Germany.
  • Beck K; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Richter D; Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Winter U; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany.
  • Wolf S; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.
  • Pfütze K; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Geörg C; DKTK, Dresden, Germany.
  • Meißburger B; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.
  • Buchhalter I; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Augustin M; DKTK, Dresden, Germany.
  • Aulitzky WE; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hohenberger P; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Kroiss M; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schirmacher P; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schlenk RF; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Keilholz U; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Klauschen F; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Folprecht G; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Bauer S; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.
  • Siveke JT; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Brandts CH; DKTK, Dresden, Germany.
  • Kindler T; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Boerries M; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Illert AL; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • von Bubnoff N; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Jost PJ; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Spiekermann K; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Bitzer M; Department of Translational Medical Oncology, NCT Dresden and DKFZ, Dresden, Germany.
  • Schulze-Osthoff K; Center for Personalized Oncology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
Cancer Discov ; 11(11): 2780-2795, 2021 11.
Article em En | MEDLINE | ID: mdl-34112699
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transcriptoma / Neoplasias Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transcriptoma / Neoplasias Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha